Q3 2025 Holdings
Filed 2025-11-14 | 76 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $230.4M | 1,600,000 | 15.6% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $76.9M | 1,400,000 | 5.2% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $60.9M | 300,000 | 4.1% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $56.9M | 1,500,000 | 3.8% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $49.4M | 1,700,000 | 3.3% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $41.2M | 750,000 | 2.8% |
| Uniqure NV(QURE) | SHS | N90064101 | $35.0M | 600,000 | 2.4% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $34.0M | 1,150,000 | 2.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $29.3M | 300,000 | 2.0% |
| Newamsterdam Pharma Company(NAMS)Put | ORDINARY SHARES | N62509109 | $28.4M | 1,000,000 | 1.9% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $28.1M | 50,000 | 1.9% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $27.9M | 1,600,000 | 1.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $27.4M | 60,000 | 1.9% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $25.6M | 200,000 | 1.7% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $25.4M | 200,000 | 1.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $24.3M | 1,500,000 | 1.6% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $23.0M | 300,000 | 1.6% |
| Radnet Inc(RDNT) | COM | 750491102 | $22.9M | 300,000 | 1.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $22.2M | 220,000 | 1.5% |
| Novo-Nordisk A S(NVO)Put | ADR | 670100205 | $22.2M | 400,000 | 1.5% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $21.1M | 150,000 | 1.4% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $20.4M | 130,000 | 1.4% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $18.8M | 2,000,000 | 1.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $18.7M | 400,000 | 1.3% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $16.2M | 85,000 | 1.1% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $16.2M | 50,000 | 1.1% |
| Elanco Animal Health Inc(ELAN) | COM | 28414H103 | $16.1M | 800,000 | 1.1% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $15.6M | 200,000 | 1.1% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $15.3M | 20,000 | 1.0% |
| CVS Health Corp(CVS) | COM | 126650100 | $15.1M | 200,000 | 1.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $14.9M | 250,000 | 1.0% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $14.4M | 100,000 | 1.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $14.3M | 150,000 | 1.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $14.3M | 400,000 | 1.0% |
| Doximity Inc(DOCS) | CL A | 26622P107 | $13.2M | 180,000 | 0.9% |
| Pfizer Inc(PFE) | COM | 717081103 | $12.7M | 500,000 | 0.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $12.7M | 50,000 | 0.9% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $12.3M | 150,000 | 0.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $11.9M | 60,000 | 0.8% |
| Fresenius Medical Care AG(FMS) | SPONSORED ADR | 358029106 | $11.8M | 450,000 | 0.8% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $11.6M | 15,000 | 0.8% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $11.6M | 90,000 | 0.8% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $11.3M | 750,000 | 0.8% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $11.2M | 550,000 | 0.8% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $11.2M | 25,000 | 0.8% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $11.2M | 65,000 | 0.8% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $10.9M | 200,000 | 0.7% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $10.8M | 575,000 | 0.7% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $10.8M | 900,000 | 0.7% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $10.6M | 1,100,000 | 0.7% |